Pathogen Bank

Our working compendium of the various pathogens associated with emerging infections.

Group 1 (HAIs)

• Category A Pathogens:

  • Bacillus anthracis, Clostridium botulinum, Yersinia pestis, Variola major (smallpox), Francisella tularensis

  • Viral Hemorrhagic Fevers (list of VHF diseases from CDC):

    • Arenaviruses (Lassa), Bunyaviruses (Hantavirus, Crimean Congo Hemorrhagic Fever), Flaviviruses (Dengue Fever), Filoviruses (Ebola, Marburg)

• Category B Pathogens:

  • Burkholderia pseudomallei, Coxiella burnetti, Brucella, Burkholderia mallei, Chlamydia psittaci, Ricin toxin, Clostridium perfringens (Epsilon), Staphylococcus enterotoxin B, Rickettsia prowazekii

  • Foodborne (A-Z index) and Waterborne Pathogens:

    • Bacteria: E. coli, Vibrio, Shigella, Salmonella, Listeria monocytogenes, Campylobacter jejuni, Yersinia enterocolitica

    • Viruses: Caliciviruses, Hepatitis A

    • Parasites: Cryptosporidium parvum, Cyclospora cayatenesis, Giardia lamblia, Entamoeba histolytica, Toxoplasma gondii, Naegleria fowleri, Balamuthia mandrillaris

    • Fungi: Microsporidia

  • Mosquito-borne Viruses:

    • West Nile Virus, LaCrosse encephalitis, California encephalitis, Venezuelan equine encephalitis, Eastern/Western equine encephalitis, Japanese encephalitis, St. Louis encephalitis, Yellow fever virus, Chikungunya virus, Zika virus

• Category C Pathogens:

  • Nipah and Hendra viruses, tickborne hemorrhagic fever viruses (2018 review article), tickborne encephalitis complex flaviviruses, TB/MDR-TB, Influenza, Rickettsia (Practical guide for providers, RMSF, Yellow Book chapter), Rabies virus, Prions, Coccidiodes, SARS, MERS, Coronaviruses (SARS-CoV-2)

  • Antimicrobial resistance, excluding research on sexually transmitted organisms, unless the resistance is newly emerging*

    • Research on mechanisms of antimicrobial resistance

    • Studies of the emergence and/or spread of antimicrobial resistance genes within pathogen populations

    • Studies of the emergence and/or spread of antimicrobial-resistant pathogens in human populations

    • Research on therapeutic approaches that target resistance mechanisms

    • Modification of existing antimicrobials to overcome emergent resistance

      *Excluded Research (Sexually Transmitted Organisms)

      Bacterial vaginosis, Chlamydia, trachomatis, cytomegalovirus, Granuloma inguinale, Haemophilus ducreyi, hepatitis B virus, hepatitis C virus, herpes simplex virus, human immunodeficiency virus, human papillomavirus, Treponema pallidum, Trichomonas vaginalis

    • Antimicrobial research, as related to engineered threats and naturally occurring drug-resistant pathogens, focused on development of broad-spectrum antimicrobials

  • Additional Emerging Infectious Diseases/Pathogens:

    • Acanthamebiasis, Anaplasmosis, Australian bat lyssavirus, Babesia (atypical), Bartonella henselae, BK virus, Bordetella pertussis, Borrelia mayonii, Borrelia miyamotoi, Ehrlichiosis, Enterovirus 68, Enterovirus 71, Hepatitis C, Hepatitis E, Human herpesvirus 6, Human herpesvirus 8, JC virus, Leptospirosis, Mucormycosis, Poliovirus, Rubeola, Group A Streptococcus

Group 2 (links to all pathogens below):

• Acinetobacter, Bukholderia cepacia, Candida auris, C. diff, C. Sordelli, Enterobacteriaceae, GN, Viral hepatitis, HIV/AIDS, Influenza, Klebsiella, MRSA, Mycobacterium abscessus, Norovirus, Pseudomonas aeruginosa, Staph aureus, TB, VISA/VRSA, VRE